
    
      This is a randomized, controlled, split mouth, prospective, single centre study. The total
      study duration for each patient should be 76 weeks +/-18 months.

      In total 8 visits per patient are scheduled in this study.

      The study devices Straumann Bone Ceramic and Bio-Oss are CE-marked, and approved by the FDA.
      The products are used within the indication.

      One center in Beligum will participate.
    
  